Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.67 USD | +4.39% | -0.47% | +11.42% |
Financials (USD)
Sales 2024 * | 141M | Sales 2025 * | 314M | Capitalization | 3.01B |
---|---|---|---|---|---|
Net income 2024 * | -333M | Net income 2025 * | -245M | EV / Sales 2024 * | 20.5 x |
Net cash position 2024 * | 123M | Net cash position 2025 * | 399M | EV / Sales 2025 * | 8.33 x |
P/E ratio 2024 * |
-8.87
x | P/E ratio 2025 * |
-11.5
x | Employees | 305 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.5% |
Latest transcript on SpringWorks Therapeutics, Inc.
1 day | +4.39% | ||
1 week | -0.47% | ||
Current month | -1.91% | ||
1 month | -9.84% | ||
3 months | -19.21% | ||
6 months | +40.53% | ||
Current year | +11.42% |
Managers | Title | Age | Since |
---|---|---|---|
Saqib Islam
CEO | Chief Executive Officer | 54 | 17-07-31 |
Daniel Lynch
CHM | Chairman | 65 | 15-12-31 |
Frank Perier
DFI | Director of Finance/CFO | 64 | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Fuhrman
BRD | Director/Board Member | 67 | 19-07-31 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 17-07-31 |
Carlos Alban
BRD | Director/Board Member | 61 | 22-07-13 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.10% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 40.67 | +4.52% | 472,564 |
24-06-04 | 38.91 | -0.92% | 835,460 |
24-06-03 | 39.27 | -5.28% | 1,251,777 |
24-05-31 | 41.46 | -2.70% | 897,157 |
24-05-30 | 42.61 | +4.28% | 548,631 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.42% | 3.01B | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+5.01% | 22.67B | |
-9.54% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- SWTX Stock